Drug

IV Biosimilar

Study Design

PD and Immunogenicity assessments

Multiple sites in EU and US In-house for few days followed by daily/weekly follow up visits

Subject Recruitment

Total 390 subjects

AXIS as rescue site during Covid-19 peak to recruit up to 50 subjects

Study outcome

Studies completed within the sponsor target timeline

Some recruitment challenges due to peak Covid-19

Interested in bringing your study to AXIS? Please reach out:

John Pottier
Senior VP Business Development